
Ostomy Devices Market Size, Share, Trends & Global Forecast 2026–2035
The Ostomy Devices Market is Segmented By Product Type (Ostomy Pouching Systems & Components (One-Piece Pouching Systems, Two-Piece Pouching Systems & Components), Ostomy Accessories & Adjuncts), By Surgery Type (Ileostomy Drainage Bags, Colostomy Drainage Bags, Urostomy Drainage Bags), By Shape of Skin Barrier (Flat, Convex), By Ostomy Type (Colostomy, Ileostomy, Urostomy), By Age Group (Adults, Pediatric), By End-User (Hospitals & ASCs, Homecare Settings, Specialty Clinics & Long-Term Care Facilities, Others) and Region
Ostomy Devices Market Overview and Definition
The Global Ostomy Devices Market was valued at USD 3.86 Billion in 2025, and is projected to reach USD 6.26 Billion by 2035, growing at a CAGR of 4.95% from 2026 to 2035. The market encompasses pouching systems, accessories, and adjunct products used by patients who have undergone surgical creation of a colostomy, ileostomy, or urostomy to manage bowel or urinary diversion. Growth is driven by rising incidence of colorectal cancer, inflammatory bowel disease, and bladder cancer requiring ostomy surgery, combined with an ageing global population and expanding access to ostomy care services in emerging markets.
Ostomy Pouching Systems and Components hold the dominant position within the market by product type, while colostomy represents the largest ostomy type segment. Homecare settings are an increasingly significant end-user channel as patients transition from hospital-based care toward long-term self-managed ostomy care. Europe leads the market in commercial maturity, while Asia-Pacific is emerging as a high-growth region supported by expanding surgical infrastructure and improving ostomy care access through the forecast period.
Key Market Trends & Analysis
- The Global Ostomy Devices Market was valued at USD 3.86 billion in 2025, reflecting consistent demand from patients managing permanent and temporary colostomies, ileostomies, and urostomies.
- The Global Ostomy Devices market is projected to grow at a CAGR of 4.95% from 2026 to 2035, supported by rising colorectal cancer incidence, inflammatory bowel disease prevalence, and expanding ostomy procedures.
- By 2035, the Global Ostomy Devices market is forecast to reach USD 6.26 billion, driven by ageing demographics, improved access to ostomy care, and innovation in skin-friendly pouching systems.
- Advancements in skin barrier technology, adhesive formulations, odour control, and extended-wear systems are improving patient comfort and reducing peristomal skin complications.
- Ostomy Pouching Systems & Components dominate the product type segment with approximately 72% market share, while Ostomy Accessories & Adjuncts are the fastest-growing category, projected to register a CAGR of 5.6%.
- Colostomy Drainage Bags dominate the surgery type segment, accounting for approximately 48% share, while Urostomy Drainage Bags are the fastest-growing category, with a projected CAGR of 5.4%.
- Flat Skin Barriers dominate the shape segment with approximately 68% market share, while Convex Skin Barriers are the fastest-growing category, projected to expand at a CAGR of 5.8%.
- Colostomy dominates the ostomy type segment with approximately 46% share, supported by colorectal cancer surgeries, while Urostomy is the fastest-growing category, with a projected CAGR of 5.3%.
- Hospitals & ASCs dominate the end-user segment, accounting for approximately 45% of market share, while Homecare Settings are the fastest-growing channel, projected to grow at a CAGR of 6.1%.
- Europe leads the global market in commercial maturity and premium product adoption, supported by established manufacturers, comprehensive reimbursement frameworks, and well-developed ostomy nursing services.
- Germany accounts for approximately 24% of the European market, supported by its large healthcare sector, established ostomy care services, and strong clinical networks for wound and ostomy nursing.
- Coloplast A/S expanded its SenSura Mio range in 2025 with enhanced skin barrier technology, targeting improved wear performance and reduced peristomal skin complications.
- Asia-Pacific is the fastest-growing regional market, projected to register a CAGR of approximately 5.8% from 2026 to 2035, driven by rising cancer surgery volumes and improving access to ostomy care products.
- The USA Ostomy Devices Market was valued at USD 0.88 billion in 2025 and is projected to reach USD 1.44 billion by 2035, growing at a CAGR of approximately 5.1%.
The ostomy market consists of various pouching systems, skin barriers, accessories and ancillary products that help patients manage output from their intestines or urine using a surgically create stoma. There are a range of key products such as single and double piece pouching systems, which come with an incorporated or separate skin barrier. Pouching systems also have a choice between a closed or drainable pouch. Urostomy pouches are available and there is a range of accessories including adhesive removers, barrier rings, stoma paste and belt supports. These are used by patients who have had their colostomy, ileostomy or urostomy created due to colorectal cancer surgery, inflammatory bowel disease, bladder cancer, trauma or congenital conditions.
Source: Kaiso Research and Consulting
Hospitals and day surgery centres are end users of these products for managing acute post-op Ostomy care. Homecare management is also used by patients for long term self-management. Speciality clinics offer Ostomy nursing services and wound care. Long term care facilities will also support elderly Ostomy patients. This market has specialist medical device manufacturers supplying products directly to patients, Ostomy nursing services, and purchasing organisations within the healthcare system.
Strategic Importance and Market Outlook
Ostomy appliances are key clinical products that define the quality of life for a large and growing number of patients. Ostomy appliances can help patients who have permanent or temporary stomas to control a key bodily function in a safe and hygienic manner. This can help patients feel confident enough to continue their social, working and personal lives. The quality of the ostomy appliance will impact a patient’s quality of life, peristomal skin integrity and the risk of re-admissions to hospital. The quality of the appliance is determined by factors such as durability, adhesion, smell and discreetness.
Innovation is being implemented within the market to help address key unmet needs within the market. Peristomal skin problems are affecting many patients and cause a significant burden on healthcare resources. Ostomy specialist nurses are increasing, telehealth is supporting ostomy care and the product is being delivered directly to patients. This is helping improve long term management for patients but also creates new routes to market for Ostomy appliance manufacturers.
Regulation in the US, Europe and key Asia Pacific countries means quality and safety standards are maintained within the market. Premium innovation is occurring to create high quality products with increased average selling prices. Between now and 2035, we see a trend toward premium products, further penetration into emerging markets and greater incorporation of digital tools to support patients with an ostomy.
In March 2025, Coloplast A/S announced the expanded commercial launch of its Brava Lubricating Deodorant and enhanced SenSura Mio Concave skin barrier within the European market, targeting patients with retracted stomas and complex peristomal skin profiles, and demonstrating continued investment in product innovation addressing unmet clinical needs within the ostomy care segment.
Recent Developments in the Ostomy Devices Market
- In January 2025, Coloplast A/S announced the commercial availability of its next-generation SenSura Mio skin barrier range featuring enhanced Mio Fit adhesive technology, designed to improve wear time, reduce peristomal skin leakage, and extend secure adhesion across active patients with high-output stomas. The launch targeted both new ostomy patients and conversion from competitor pouching systems across European and North American markets.
- In March 2025, Convatec announced the expansion of its Me+ ostomy patient support programme into additional European markets, integrating digital coaching, remote ostomy nursing consultation, and personalised product recommendation tools to improve long-term patient self-management capability and product adherence among newly formed and established ostomy patients.
- In May 2025, Hollister Incorporated introduced an updated range of CeraPlus skin barrier pouching systems incorporating ceramide-enhanced adhesive technology, targeting the reduction of peristomal skin complications through improved moisture management and skin microbiome protection. The innovation addressed one of the most clinically significant unmet needs in long-term ostomy patient management.
- In February 2025, Salts Healthcare announced the launch of its Confidence BE range of one-piece and two-piece ostomy pouching systems featuring a new breathable and flexible skin barrier construction, designed to improve patient comfort and wear security during physical activity and in warmer climates, expanding the product's addressable patient population across the UK and export markets.
- In April 2025, Eakin Healthcare Group announced a strategic partnership with a European homecare supply organisation to expand the distribution reach of its Eakin Cohesive skin barrier and ostomy accessory range, strengthening direct-to-patient supply capability and improving product access for ostomy patients transitioning from hospital to home-based long-term care management.
Ostomy Devices Market Dynamics: Drivers, Restraints, Opportunities, Challenges and Trends
Drivers: Rising colorectal cancer and inflammatory bowel disease incidence expands the global ostomy procedure and patient management population.
Colorectal cancer is the third most common cancer worldwide. Surgical treatments often involve creation of a permanent or temporary colostomy/ileostomy. Rising prevalence of colorectal cancer due to dietary changes, increased age groups and increased cancer screening rates in under-screened populations is increasing the number of surgical procedures to create an ostomy each year. IBD such as Crohn’s disease and ulcerative colitis provides another large source of ileostomies.
Patients will carry an ostomy for many years meaning these patients have a high lifetime value to ostomy device companies. Global surgery oncology is increasing, especially in Asia Pacific and Latin American countries. This has created more patients with colorectal and bladder cancer who would have otherwise gone untreated or received palliative care. These patients now qualify for surgery and require ostomy devices. This creates a growing and diversified patient base for ostomy devices.
Restraints: Social stigma, limited ostomy nursing access, and patient adherence challenges constrain long-term device management quality and market development.
The clinical benefit of ostomy appliances can be offset by many social factors, leading to patients not choosing the best pouching system and accessories. This can lead to patients not using the right products, putting up with avoidable peristomal skin issues and not upgrading to more high-end pouching systems. As a result, the market is not performing to its full potential as there is a significant proportion of patients who are not being actively managed by ostomy nurses.
Access to trained ostomy nursing professionals varies greatly worldwide. Nurse-led Ostomy services are well established in Northern and Western Europe. However, there are significant gaps in community-led Ostomy nursing provision in Eastern Europe, Asia Pacific, Latin America and Africa. Patients in these low access markets will be less likely to use high-end or the most clinically appropriate products without professional guidance, therefore reducing average revenue per patient and limiting the addressable market in regions where ostomy procedures are increasing.
Opportunities: Emerging market ostomy surgical expansion and improving healthcare infrastructure create new high-volume patient population access opportunities.
Asia Pacific, Latin America and the Middle East are strategic growth areas. Increasing rates of colorectal and bladder cancers, coupled with increased hospital capacity and improved post operative care systems have created a large new patient base who will require long term ostomy devices. The increasing number of oncology surgeries in countries such as China, India, Brazil and Saudi Arabia creates an opportunity to increase sales in these countries disproportionately.
New products can be developed locally and a direct to patient supply chain created. Ostomy education programs can be created which are specific to the needs of the patients in these emerging markets. Working with local distributors, patient support groups and surgical oncology programs can help increase market penetration and develop the patient base.
Challenges: Reimbursement variability and healthcare system procurement constraints limit patient access to premium ostomy device categories.
Ostomy products are reimbursed in a variety of ways in major markets. Patients have access to a large range of premium quality products and manufacturers have good revenue per patient in countries with a generous, well defined reimbursement scheme such as Denmark, the UK and Germany. Where reimbursement is capped or restricted, patients will have less access to premium quality products which include premium pouching systems and accessories, due to the lack of reimbursement.
Procurement and tendering is becoming consolidated in many European markets meaning manufacturers face significant pressure on price. This also creates some challenges for manufacturers who offer higher quality products as these cannot be differentiated clinically within tenders. Smaller niche manufacturers find it difficult to position themselves with premium quality products where leading brand manufacturers have an advantage due to having a larger share in the country.
Trends: Skin-friendly adhesive innovation and extended-wear skin barrier technology address the ostomy market's most significant clinical and commercial quality improvement opportunity.
Peristomal skin problems such as dermatitis, irritation and moisture-associated skin damage will affect the majority of patients with ostomies and are the most commercially significant driver for adopting premium products. Manufacturers are investing in new products containing ceramides in skin barriers, absorbent adhesives and adaptable skin barriers to address this issue. This means there is a strong incentive for patients with skin issues to switch to premium products.
This means there is an incentive to improve quality of life for patients by improving the skin barriers. Ostomy nurses and wound care professionals are key influencers in hospitals and the community. They see the peristomal skin issues and have a strong influence for using premium skin barriers. Their recommendation to use premium skin barriers with improved quality will drive product conversion and increase premium market share in mature markets.
Where Are the Biggest Opportunities in the Ostomy Devices Market?
- Premium skin barrier and extended-wear pouching system adoption among established ostomy patients experiencing peristomal skin complications offers significant conversion revenue opportunity.
- Emerging market surgical oncology expansion in Asia-Pacific, Latin America, and the Middle East creates large new ostomy patient populations with long-term device management requirements.
- Homecare direct-to-patient supply model development improves access, adherence, and product upgrade rates among long-term ostomy patients transitioning from hospital-based care.
- Two-piece pouching system growth addresses demand from patients and clinicians requiring flexible stoma management solutions for complex, retracted, or irregular stoma presentations.
- Digital ostomy care support platforms integrating telehealth nursing, product guidance, and adherence monitoring create new patient engagement and premium product access pathways.
- Paediatric ostomy device innovation addresses the distinct anatomical, adhesive, and quality-of-life requirements of children with congenital and acquired ostomy formations.
- Convex skin barrier technology growth serves the significant patient population with retracted or flush stomas requiring modified barrier geometry for secure adhesion and leak prevention.
- Ostomy accessory and adjunct product expansion — including barrier rings, stoma paste, adhesive removers, and support belts — generates incremental per-patient revenue alongside core pouching system sales.
- Patient education and ostomy nurse training programme investment in under-resourced markets improves product awareness and clinical management quality for growing surgical patient populations.
- Sustainable and skin-sensitisation-reduced adhesive material development addresses growing patient and regulatory demand for hypoallergenic, environmentally considerate ostomy device solutions.
Ostomy Devices Market Segmentation Analysis
Report Attributes | Details |
Market Size in 2025 | USD 3.86 Billion |
Market Size by 2035 | USD 6.26 Billion |
CAGR (2026-2035) | 4.95% |
Base Year | 2025 |
Forecast Period | 2026-2035 |
Historical Data | 2022-2024 |
Report Scope & Coverage | Market Size, Segments Analysis, Competitive Landscape, Regional Analysis, Analysis, Forecast Outlook |
Key Segments | By Product Type:
By Surgery Type: Ileostomy Drainage Bags, Colostomy Drainage Bags, Urostomy Drainage Bags By Shape of Skin Barrier: Flat, Convex By Ostomy Type: Colostomy, Ileostomy, Urostomy By Age Group: Adults, Pediatric By End-User: Hospitals & ASCs, Homecare Settings, Specialty Clinics & Long-Term Care Facilities, Others |
Regional Analysis/Coverage | North America (U.S., Canada, Mexico), Europe (UK, Germany, France, Spain, Italy, Rest of Europe), Asia-Pacific (China, India, Japan, Australia, South Korea, Rest of Asia-Pacific), LAMEA (Brazil, Argentina, UAE, Saudi Arabia, Africa, Rest of Latin America) |
Company Profiles | Coloplast A/S (Denmark), Hollister Incorporated (U.S.), Convatec (U.K.), B. Braun SE (Germany), Salts Healthcare (U.K.), Eakin Healthcare Group (U.K.), Welland Medical Limited (U.K.), ALCARE Co., Ltd. (Japan), Unora Healthcare Ltd. (U.K.), Cymed (U.S.) |
Source: Kaiso Research and Consulting
Ostomy Devices Market Segment Analysis
- By Product Type, Ostomy Pouching Systems & Components dominated the "Ostomy Devices" Market in 2025 with approximately 72% share; Ostomy Accessories & Adjuncts is the fastest-growing segment with a CAGR of approximately 5.6% from 2026 to 2035.
- By Surgery Type, Colostomy Drainage Bags dominated the "Ostomy Devices" Market in 2025 with approximately 48% share; Urostomy Drainage Bags is the fastest-growing segment with a CAGR of approximately 5.4% from 2026 to 2035.
- By Shape of Skin Barrier, Flat dominated the "Ostomy Devices" Market in 2025 with approximately 68% share; Convex is the fastest-growing segment with a CAGR of approximately 5.8% from 2026 to 2035.
- By Ostomy Type, Colostomy dominated the "Ostomy Devices" Market in 2025 with approximately 46% share; Urostomy is the fastest-growing segment with a CAGR of approximately 5.3% from 2026 to 2035.
- By Age Group, Adults dominated the "Ostomy Devices" Market in 2025 with approximately 88% share; Pediatric is the fastest-growing segment with a CAGR of approximately 5.7% from 2026 to 2035.
- By End-User, Hospitals & ASCs dominated the "Ostomy Devices" Market in 2025 with approximately 45% share; Homecare Settings is the fastest-growing segment with a CAGR of approximately 6.1% from 2026 to 2035.
Dominating Segments in the Ostomy Devices Market
By Product Type: Ostomy pouching systems sustain consumable-driven market dominance as accessories and adjuncts record accelerating adoption growth.
Ostomy Pouching Systems and Components dominate the market, representing around 72% of total market value in 2025. Due to their nature as single-use products, the patient will need to replace their pouch and skin barrier regularly throughout their ostomy journey. This leads to a high market revenue as they are continuously used. Both one-piece and two-piece systems can be used in patients with a colostomy, ileostomy or urostomy.
Ostomy Accessories and Adjuncts is the fastest growing market segment. It has a CAGR of approximately 5.6% between 2026 and 2035. Accessory products such as barrier rings, stoma paste, adhesive removers, skin protectant wipes and support belts are becoming recognised as playing a key role in preventing skin complications around the stoma, improving security of the Ostomy pouching systems and improving quality of life for patients. As nursing practices and patient education improves, the accessories products are being used more in patients. This therefore increases the amount of revenue generated from this product for each patient.
In January 2025, Coloplast A/S expanded its Brava accessory range with the commercial launch of enhanced barrier ring and adhesive remover formulations, designed to address peristomal skin protection and system security requirements for active patients and those with complex stoma presentations across European and North American markets.
By Surgery Type: Colostomy drainage bags sustain procedural volume dominance as urostomy bags record the fastest surgery-type growth trajectory.
The largest surgery type segment for Ostomy Devices is Colostomy Drainage Bags which accounted for around 48% of market value in 2025. This is due to it being the most common ostomy creation procedure. It is driven by colorectal cancer surgery, complications from diverticular disease and bowel trauma. A high incidence of colorectal cancer worldwide and a large number of patients having either permanent or long term temporary colostomy formation means there is a steady high demand for colostomy drainage bags in both developed and emerging countries.
The fastest growing surgery type segment is Urostomy Drainage Bags. With an expected CAGR of around 5.4% between 2026 and 2035. This is due to an increase in bladder cancer cases, more radical cystectomy procedures being used to treat muscle invasive bladder cancer and increased access to urostomy procedures in emerging countries. Urostomy Devices have specific requirements which include anti reflux valves, larger capacity bags and specific skin barriers for urine. This creates a high demand for premium products and therefore revenue growth will be above average in this surgery type.
In May 2025, Hollister Incorporated introduced an updated range of Moderma Flex urostomy pouching systems with enhanced anti-reflux valve technology and improved skin barrier adhesion, targeting urostomy patients requiring secure long-wear performance and robust urine management for active daily living.
By Shape of Skin Barrier: Flat skin barriers dominate broad patient access as convex barriers emerge as the fastest-growing format for complex stoma management.
Flat skin barriers dominate the Ostomy Devices market. In 2025 flat skin barriers account for approx. 68% of the market value. These are ideal for most Ostomy patients, as most will have even skin around their stoma. They are the first port of call for Ostomy Pouching Systems in post-op in hospitals and for long-term Ostomy patients. This is due to their wide range of applications, availability from all major manufacturers and can fit into one and two piece systems.
Convex skin barriers are the fastest growing skin shape category. They are forecasted to grow at a CAGR of approx. 5.8% between 2026-2035. Convex skin barriers are indicated for patients with sunken, flat skin or problematic skin around their stoma. This affects a significant proportion of Ostomy patients and can cause high rates of skin issues around the stoma. Awareness of the indications for convex skin barriers are increasing. Ostomy nurses have been educating patients and manufacturers have clinical support programs to increase appropriate usage of convex skin barriers.
In February 2025, Salts Healthcare launched its Confidence BE Convex range, incorporating a new flexible convex skin barrier construction designed to improve peristomal seal security for patients with retracted stomas while providing greater body-conforming comfort compared to conventional rigid convex barrier systems.
By Ostomy Type: Colostomy sustains the largest ostomy type patient base as urostomy records the fastest segment growth through bladder cancer surgical volume expansion.
The colostomy segment will dominate the ostomy devices market, representing roughly 46% of total market value in 2025. The global burden of colorectal cancer, diverticular disease and bowel trauma means colostomy is the most common type of ostomy performed. This, in-turn, provides the largest growth driver for the number of patients living with a long term Ostomy. Due to the high numbers of permanent colostomies formed post-abdominoperineal resection for lower rectal cancer, there is a large patient cohort with lifelong dependence on colostomy devices; creating predictable and steady demand for consumables across all key global markets.
The urostomy segment is expected to be the fastest growing segment of Ostomy types, growing at a CAGR of around 5.3% from 2026 to 2035. As the global incidence of bladder cancer increases, and radical cystectomy with ileal conduit is increasingly becoming the gold standard treatment for muscle invasive bladder cancer, this will drive growth. Bladder cancer screening rates are improving in APAC and Latin America, leading to increased numbers of urostomies being performed outside of NA and Europe.
In March 2025, Convatec announced the expansion of its Esteem synergy urostomy range with the commercial introduction of enhanced anti-reflux valve technology and extended-wear skin barrier formulations, targeting long-term urostomy patients requiring improved overnight security and reduced peristomal skin irritation from prolonged urine exposure.
By Age Group: Adults dominate the ostomy devices market as paediatric patients represent the fastest-growing age group through improving congenital care outcomes.
The largest demographic in the Ostomy Devices market is adults, which will account for around 88% of the total market value in 2025. This is due to the main reasons for undergoing an Ostomy being related to colorectal cancer, bladder cancer, diverticular disease, and inflammatory bowel disease. These are predominantly suffered by adults and the elderly. Older adults with colorectal cancer are likely to suffer from permanent ostomies. This means there will be a steady demand for these products.
The fastest growing segment in terms of demographic is paediatrics. This segment is expected to grow at a CAGR of around 5.7% between 2026-2035. This is due to improved survival rates in infants and children with congenital conditions such as Hirschsprung's disease, Anorectal malformations, Necrotising Enterocolitis and Bladder Exstrophy who require an Ostomy. Due to the different anatomy of children, they require Ostomy devices specifically designed for paediatrics. As they have sensitive adhesives and are still developing their pouching systems. This results in a premium product.
In April 2025, Coloplast A/S announced the expansion of its paediatric ostomy product portfolio with the introduction of new SenSura Mio Kids pouching system sizes and skin barrier formulations, specifically developed to address the adhesive sensitivity, size, and flexibility requirements of infant and young child stoma management across hospital and homecare settings.
By End-User: Hospitals and ASCs anchor procedural volume and acute care device demand as homecare settings emerge as the market's fastest-growing end-user channel.
Hospitals & ASCs are the largest segment in the Ostomy Devices market, accounting for around 45% of the total market in 2025. Hospitals manage the most critical part of the Ostomy care pathway, managing the acute post-operative period of Ostomy care. During this period specialist Ostomy Nurses will assess the formation of the stoma, select appropriate Ostomy pouching systems and provide initial patient education. Hospitals will also have a high number of Surgical Oncology, Colorectal and Urology programs meaning they are the main source for initial device selection and Ostomy patient education.
Homecare Settings is the fastest growing segment in Ostomy Devices market, growing at a CAGR of around 6.1% from 2026 to 2035. Homecare is where Ostomy patients will go to manage their Ostomy long term. This means Ostomy Devices will be used on an ongoing basis here. As more Direct to Patient Ostomy supply programs, Ostomy Nursing Telehealth Services and Patient Support programs are implemented, the commercial infrastructure within Homecare is increasing, allowing Ostomy Device manufacturers to maintain direct relationships with Ostomy patients.
In March 2025, Convatec announced the expansion of its Me+ digital ostomy patient support programme into additional European homecare markets, integrating remote ostomy nursing consultation, personalised product guidance, and digital adherence coaching to improve long-term patient self-management quality and product optimisation within the homecare setting.
Regional Insights in the Ostomy Devices Market
Regional Analysis:
Region | Major Country | Share within Region, 2025 (%) |
North America | USA | 76% |
Europe | Germany | 24% |
Asia Pacific | China | 33% |
Latin America | Brazil | 44% |
North America: North America leads ostomy device adoption through high surgical volumes, homecare reimbursement infrastructure, and premium product market maturity.
North America is a mature and high value region that will see a CAGR of around 4.8% between 2026 and 2035. This is due to the region having high volumes of patients undergoing colorectal and bladder cancer surgery. This is supported by strong homecare medical supply reimbursement and a high level of understanding of advanced ostomy pouching and accessories among patients and professional teams. North America also has well supported healthcare systems with many specialist wound, ostomy and continence nurses in the USA and Canada.
Approximately 76% of market share comes from the USA. The Medicare and Medicaid programmes are well established, along with insurance benefits. This means there is a clear reimbursement structure for patients undergoing ostomy pouching. This creates a stable demand for products with a large patient base. The homecare market is well established with specialist ostomy product distributors supplying directly to patients.
In June 2025, Hollister Incorporated announced the expansion of its USA direct-to-patient ostomy supply and support programme, integrating telehealth-connected ostomy nursing consultation services with personalised product delivery to improve access to clinical guidance and premium pouching products for homecare ostomy patients across the country.
USA: USA ostomy device demand is sustained by colorectal cancer surgery volumes, established homecare supply networks, and premium product conversion programmes.
The Ostomy Devices market in the USA was valued at USD 0.88 billion in 2025, and is forecast to grow at a CAGR of ~5.1% to USD 1.44 billion by 2035. The USA constitutes ~76% of the North America market and is the largest single country market in the world. This is driven by the high rates of colorectal cancer surgeries, large patient pool and strong reimbursement and homecare supply.
There is a complete supply chain for Ostomy products to the market. Leading global Ostomy Device companies such as Coloplast, Hollister and Convatec have their main presence in the USA. They compete with each other to gain market share through innovation, building relationships with Ostomy Nurses and investing in patient adherence programmes.
There is a strong presence of wound, ostomy and continence nurses in hospitals and within the community. These nurses are the key decision makers and recommend the more innovative skin barriers and premium accessories. The aging population within the USA, along with increasing colorectal cancer rates in those under 50 years old will continue to increase the number of procedures performed and patients in the USA.
In May 2025, Coloplast A/S announced the expansion of its USA patient support programme, Coloplast Care, with the introduction of dedicated digital coaching and telehealth ostomy nursing services for newly formed ostomy patients, targeting improved product confidence, skin management outcomes, and quality of life during the critical first year of ostomy adjustment.
Europe: Europe leads global ostomy device innovation and premium adoption through comprehensive nursing infrastructure and clean reimbursement frameworks.
Europe is the most clinically developed region of the Ostomy Devices market. The region will grow at a CAGR of approximately 4.4% from 2026-2035. Europe is home to the leading Ostomy Device manufacturers globally. Leading manufacturers include Coloplast, Convatec, Hollister, Salts Healthcare, Eakin Healthcare Group and Welland Medical. These companies invest heavily in R&D into their products within Europe. Europe has therefore created a positive feedback loop of high quality Ostomy devices being developed and adopted.
Germany makes up approximately 24% of the Ostomy Devices market in Europe. Germany is the largest healthcare economy in the continent and has fully developed hospital and community Ostomy Care services. There are clear reimbursement systems in place for Ostomy Products. The UK, Denmark, Netherlands and Nordic countries are some of the highest quality Ostomy Device users. They have fully developed community Ostomy Nursing services which encourage adoption of high quality products. Eastern Europe offers an opportunity for growth with increased access to colorectal surgery.
In January 2025, Coloplast A/S launched its expanded SenSura Mio range across European markets, incorporating enhanced Mio Fit adhesive skin barrier technology targeting extended secure wear and improved peristomal skin health outcomes for colostomy, ileostomy, and urostomy patients across hospital and community care settings.
Asia-Pacific: Asia-Pacific records the fastest ostomy device growth as colorectal cancer surgery expansion and improving product access converge across the region.
The Asia Pacific region will grow at the fastest rate of all markets for ostomy devices (approx. 5.8% CAGR between 2026-2035). This is driven by increases in the prevalence of colorectal and bladder cancers in an aging and urbanising population, increased availability of surgical oncology infrastructure in China, India, South East Asia and Australia, plus increased awareness of modern ostomy products and services in these areas. Increasing patient numbers undergoing this procedure, combined with traditionally low levels of quality and spend per patient creates great opportunities for this market.
The Chinese market will account for approx. 33% of Asia Pacific’s ostomy device market due to its large healthcare economy. There has been a rapid increase in the surgical capacity for colorectal cancer in China. The Indian market represents the biggest high-growth opportunity in Asia Pacific. Increasing patient numbers undergoing cancer surgery, increased private hospital infrastructure and increasing patient awareness creates new opportunities for standard and premium Ostomy devices. Japan and Australia represent secondary markets. They have well-established Ostomy services and show similar purchasing patterns of premium devices like those seen in Western Europe. They provide steady revenue into the Asia Pacific region.
In July 2025, Hollister Incorporated announced the expansion of its Asia-Pacific commercial infrastructure, establishing dedicated ostomy care clinical support teams in China and India to support healthcare provider education, patient awareness programme development, and premium ostomy product adoption across the region's rapidly expanding surgical oncology patient populations.
Japan: Japan sustains ostomy device demand through an ageing surgical population, established ostomy care culture, and premium product adoption standards.
The Japan Ostomy Devices market represents around 20% of the overall Asia Pacific Ostomy Devices market. This is due to Japan being one of the most advanced, high-end Ostomy Devices markets. The aging population has resulted in a constant increase in surgeries to treat colorectal cancer and diverticular disease resulting in steady increases in the number of ostomies being formed. The high standards for medical devices within the Japanese healthcare system, alongside excellent hospital based nursing care and post-hospital care means there is a steady adoption of high-end products within Japan.
The Japan Ostomy Devices market will grow at a CAGR of around 4.6% between 2026-2035. ALCARE Co., Ltd. have a strong presence in the Japanese Ostomy Devices market. They have strong clinical relationships and products designed specifically for Japan. They also offer a wide range of accessories to meet the specific needs of Japanese Ostomy patients and clinicians. There are strict regulations to ensure high quality products within Japan, as defined by the Pharmaceutical and Medical Device Act. This gives assurance to patients that products, whether domestically or internationally sourced, will meet the required standards.
In June 2025, ALCARE Co., Ltd. announced the launch of an expanded range of one-piece colostomy pouching systems with enhanced Japanese-market-specific skin barrier formulations, targeting improved wear security and peristomal skin protection for Japan's large and growing population of colorectal cancer surgery ostomy patients.
LAMEA: LAMEA presents emerging ostomy device growth as Brazil anchors Latin American surgical demand and Middle Eastern healthcare investment expands access.
LAMEA (Latin America, Middle East, Africa) is showing strong growth at around 5.2% CAGR between 2026-2035. This is largely due to increasing numbers of patients having surgery for Colorectal Cancer combined with the expansion of hospital facilities plus increased access to modern Ostomy Products. Within Latin America, Brazil makes up around 44% of the Ostomy Devices Market in the region. This is due to the size of their healthcare sector being the largest in Latin America. Public and private hospitals have significant capacity for Colorectal Surgery.
Within the Middle East (Saudi Arabia, UAE, Israel), there is the most potential to grow in the region. The high quality hospitals and expanding oncology surgeries help, but the governments are investing in healthcare and medical devices are a key area to invest in. Within Africa, there is the biggest potential for long term growth. Increasing access to healthcare means more patients are becoming aware of Cancer and countries like South Africa, Egypt and Nigeria have expanding facilities for surgery. This means new patients requiring Ostomy Devices.
In August 2024, Convatec announced the expansion of its commercial distribution partnerships across Middle Eastern markets, strengthening ostomy device product availability and patient support programme access within Saudi Arabia and UAE healthcare systems as part of a broader emerging market commercial development strategy.
How Can Stakeholders Benefit from the Ostomy Devices Market Report?
- The report offers a quantitative assessment of market segments, emerging trends, projections, and market dynamics for the period 2024 to 2035.
- The report presents comprehensive market research, including insights into key growth drivers, challenges, and potential opportunities.
- Porter's Five Forces analysis evaluates the influence of buyers and suppliers, helping stakeholders make strategic, profit-driven decisions and strengthen their supplier-buyer relationships.
- A detailed examination of market segmentation helps identify existing and emerging opportunities.
- Key countries within each region are analysed based on their revenue contributions to the overall market.
- The positioning of market players enables effective benchmarking and provides clarity on their current standing within the industry.
- The report covers regional and global market trends, major players, key segments, application areas, and strategies for market expansion.

